Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis
NCT ID: NCT00453401
Last Updated: 2008-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
1000 participants
INTERVENTIONAL
2007-02-28
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NB-001
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good general health
* History of recurrent herpes labialis with at least 3 episodes per year
Exclusion Criteria
* Lesions or irritation on or around the lips that would interfere with recognition of a herpes labialis attack
* Treatment with topical steroids, antivirals, or new topical products on or around the lips in the week prior to the onset of an attack
* Known allergies to topical creams, ointments or medications.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NanoBio Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NanoBio Corporation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Abramovits, MD
Role: PRINCIPAL_INVESTIGATOR
Dermatology Treatment and Research Center
Jeffrey Adelglass, MD
Role: PRINCIPAL_INVESTIGATOR
Research Across America
Maurice Archuleta, MD
Role: PRINCIPAL_INVESTIGATOR
Front Range Clinical Research
Brian Bock, DO
Role: PRINCIPAL_INVESTIGATOR
Bock Clinical Research Incorporated
Alicia Bucko, DO
Role: PRINCIPAL_INVESTIGATOR
Academic Dermatology Associates
Teresa Coats, MD
Role: PRINCIPAL_INVESTIGATOR
Benchmark Research
Lisa Cohen, DO
Role: PRINCIPAL_INVESTIGATOR
Suncoast Clinical Research
John Eck, MD
Role: PRINCIPAL_INVESTIGATOR
Advanced Clinical Research Incorporated
Douglass Forsha, MD
Role: PRINCIPAL_INVESTIGATOR
South Valley Dermatology Center
David Fried, MD
Role: PRINCIPAL_INVESTIGATOR
Omega Medical Research
Helen Henry, MD
Role: PRINCIPAL_INVESTIGATOR
Westover Heights Clinic
Michael T Jarratt, MD
Role: PRINCIPAL_INVESTIGATOR
Derm Research Incorporated
Terry Jones, MD
Role: PRINCIPAL_INVESTIGATOR
J & S Studies
Steven Kaster, MD
Role: PRINCIPAL_INVESTIGATOR
Wenatchee Valley Medical Center
Leon Kircik, MD
Role: PRINCIPAL_INVESTIGATOR
DermResearch, PLCC
Ronica Kluge, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical Physiology Associates
Elias Kolettis, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical Research of West Florida
Oswald Mikell, MD
Role: PRINCIPAL_INVESTIGATOR
Okati Research Center, LLC
Eugene Monroe, MD
Role: PRINCIPAL_INVESTIGATOR
Advance Healthcare
Edward Pornoy, MD
Role: PRINCIPAL_INVESTIGATOR
Westlake Medical Research
Harvey Resnick, MD
Role: PRINCIPAL_INVESTIGATOR
R/D Clinical Research Incorporated
Dennis Riff, MD
Role: PRINCIPAL_INVESTIGATOR
Advanced Clinical Research Institute
Mark A Ringold, MD
Role: PRINCIPAL_INVESTIGATOR
New River Valley Research Institute
Ronald Savin, MD
Role: PRINCIPAL_INVESTIGATOR
PC
Daniel Stewart, MD
Role: PRINCIPAL_INVESTIGATOR
MI Center for Skin Care Research
Cynthia B Strout, MD
Role: PRINCIPAL_INVESTIGATOR
Coastal Carolina Research Center
Wayne Harper, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Research Associates, LLM
Timothy Howard, MD
Role: PRINCIPAL_INVESTIGATOR
Medical Affiliated Reseach Center Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Affiliated Research Center, Inc.
Huntsville, Alabama, United States
Advanced Clinical Research Institute
Anaheim, California, United States
Westlake Medical Research
Westlake Village, California, United States
Front Range Clinical Research
Wheat Ridge, Colorado, United States
The Savin Center, PC
New Haven, Connecticut, United States
Clinical Research of West Florida
Clearwater, Florida, United States
Clinical Physiology Associates
Fort Myers, Florida, United States
Suncoast Clinical Research
New Port Richey, Florida, United States
Advanced Clinical Research, Inc.
Boise, Idaho, United States
DermResearch, PLCC
Louisville, Kentucky, United States
MI Center for Skin Care Research
Clinton Township, Michigan, United States
Academic Dermatology Associates
Albuquerque, New Mexico, United States
Wake Research Associates, LLM
Raleigh, North Carolina, United States
Westover Heights Clinic
Portland, Oregon, United States
Lederach Family Medicine
Harleysville, Pennsylvania, United States
Omega Medical Research
Warwick, Rhode Island, United States
Okatie Research Center, LLC
Beaufort, South Carolina, United States
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
Benchmark Research
Austin, Texas, United States
DermResearch Inc.
Austin, Texas, United States
J&S Studies Inc.
Bryan, Texas, United States
Dermatology Treatment & Research Center
Dallas, Texas, United States
Research Across America
Dallas, Texas, United States
R/D Clinical Research, Inc
Lake Jackson, Texas, United States
South Valley Dermatology Center
West Jordan, Utah, United States
New River Valley Research Institute
Christiansburg, Virginia, United States
Wenatchee Valley Medical Center
Wenatchee, Washington, United States
Advanced Healthcare
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NB-001-003
Identifier Type: -
Identifier Source: org_study_id